Education
About Us
Working with TipRanks
Follow Us
Tourmaline Bio (TRML)
NASDAQ:TRML
Tourmaline Bio (TRML) Ownership Overview
7.80% Insiders
7.32% Mutual Funds
61.50% Other Institutional Investors
8.83% ETFs
14.55% Public Companies and
Individual Investors
The ownership structure of Tourmaline Bio (TRML) stock is a mix of institutional, retail, and individual investors. Approximately 77.66% of the company’s stock is owned by Institutional Investors, 7.80% is owned by Insiders, and 14.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 22, 2024 | xxxxxxxxxxxxx | $26418 | |
Aug 20, 2024 | xxxxxxxxxxxxx | $71998 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $379824 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $967508 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $2434908 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,538,925 | Institution | 9.88% | 57,303,537 | |
| 1,145,646 | Institution | 4.46% | 25,857,230 | |
| 1,012,880 | Institution | 3.94% | 22,860,702 | |
| 974,558 | Insider | 3.79% | 21,995,774 | |
| 856,328 | Institution | 3.33% | 19,327,323 | |
| 742,209 | Insider | 2.89% | 16,751,657 | |
| 265,380 | Institution | 1.03% | 5,989,627 | |
| 194,246 | Institution | 0.76% | 4,384,132 | |
| 133,057 | Institution | 0.52% | 3,003,096 | |
| 85,177 | Institution | 0.33% | 1,922,445 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,012,880 | Institution | 3.94% | 22,860,702 | |
| 265,380 | Institution | 1.03% | 5,989,627 | |
| 194,246 | Institution | 0.76% | 4,384,132 | |
| 133,057 | Institution | 0.52% | 3,003,096 | |
| 65,847 | Institution | 0.26% | 1,486,167 | |
| 50,374 | Institution | 0.20% | 1,136,941 | |
| 30,069 | Institution | 0.12% | 678,657 | |
| 19,876 | Institution | 0.08% | 448,601 | |
| 13,817 | Institution | 0.05% | 311,850 | |
| 12,005 | Institution | 0.05% | 270,953 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 724,546 | Institution | 2.82% | 16,034,203 | |
| 463,284 | Institution | 1.80% | 10,456,320 | |
| 205,497 | Institution | 0.80% | 4,547,649 | |
| 164,583 | Institution | 0.64% | 3,685,013 | |
| 99,842 | Institution | 0.39% | 2,253,434 | |
| 89,949 | Institution | 0.35% | 1,990,571 | |
| 51,046 | Institution | 0.20% | 1,142,920 | |
| 43,559 | Institution | 0.17% | 975,286 | |
| 43,029 | Institution | 0.17% | 963,419 | |
| 24,092 | Institution | 0.09% | 543,756 |
FAQ
Who Owns Tourmaline Bio (TRML)?
According to the latest TipRanks data, approximately 61.50% of the company's stock is held by institutional investors, 7.80% is held by insiders, and 14.55% is held by retail investors.
What percentage of Tourmaline Bio (TRML) stock is held by institutional investors?
According to the latest TipRanks data, approximately 61.50% of Tourmaline Bio (TRML) stock is held by institutional investors.
What percentage of Tourmaline Bio (TRML) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.55% of Tourmaline Bio (TRML) stock is held by retail investors.
Who owns the most shares of Tourmaline Bio (TRML)?
Peter Kolchinsky owns the most shares of Tourmaline Bio (TRML).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.